AstraZeneca is stepping further into the obesity field with an option for a fledgling startup that seeks to preserve muscle ...
The digital health company Hims & Hers has started prescribing a cheaper, compounded version of a popular GLP-1 weight loss ...
As Novo Nordisk hauls in huge sales from its popular GLP-1 products, the company is thinking about a future beyond obesity ...
AstraZeneca said it will continue to be the conduit for sharing Chinese innovation with the rest of the world, but will ...
Larimar Therapeutics’ stock $LRMR shot up by as much as 20% after announcing Monday that the FDA had lifted its partial ...
Plus, news about BioNTech, Medigene, YGION Biomedical, Eli Lilly and Alloy Therapeutics: Lyra lays off 87 employees: The Watertown, MA-based biotech will let go of 75% of its workforce, stop ...
Investors continue to flock toward antibody-drug conjugates. Pheon Therapeutics is the latest to catch the tailwinds of the ...
LabGenius has secured £35 million ($44.5 million) in a Series B raise to expand its antibody discovery platform and advance a ...
At least seven members of Congress since 2023 have bought and sold stocks of life science companies that would gain from ...
AstraZeneca on Monday morning unveiled its ambitious plan to be one of the fastest growing pharma companies by the end of the ...
Senate Finance Chair Ron Wyden is pressing Pfizer over its tax practices as part of his investigation into how ...
A new biotech emerged to take forward the lead preclinical work developed by Frequency Therapeutics, a regenerative medicines ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results